3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Neoplasms
4
Sarcoma
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thymus Neoplasms
1
Sarcoma, Synovial
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Meningioma
1
Melanoma
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Fatigue
1
Dermatofibrosarcoma
1
Cardiovascular Diseases
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Bone Neoplasms
1
Adenocarcinoma
1
Interventions
Doxorubicin
4
pembrolizumab
3
Specimen Handling
3
toripalimab
2
abemaciclib
2
Radiotherapy
2
Magnetic Resonance Spectroscopy
2
Ifosfamide
2
Biopsy
2
silmitasertib
1
selinexor
1
peposertib
1
pemigatinib
1
pazopanib
1
palbociclib
1
mirdametinib
1
liposomal doxorubicin
1
X-Rays
1
Vincristine
1
Trabectedin
1
Temozolomide
1
Surgical Procedures, Operative
1
Radiation
1
Quality of Life
1
Proton Therapy
1
Neoadjuvant Therapy
1
Irinotecan
1
Injections
1
Histamine H2 Antagonists
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Liposarcoma
×
Quality of Life
×
Clear all
NCT07169344
2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2
Recruiting
110 enrolled